Hidetaka Uramoto

8.8k total citations · 2 hit papers
323 papers, 6.3k citations indexed

About

Hidetaka Uramoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hidetaka Uramoto has authored 323 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Pulmonary and Respiratory Medicine, 111 papers in Oncology and 66 papers in Surgery. Recurrent topics in Hidetaka Uramoto's work include Lung Cancer Treatments and Mutations (107 papers), Lung Cancer Diagnosis and Treatment (99 papers) and Lung Cancer Research Studies (29 papers). Hidetaka Uramoto is often cited by papers focused on Lung Cancer Treatments and Mutations (107 papers), Lung Cancer Diagnosis and Treatment (99 papers) and Lung Cancer Research Studies (29 papers). Hidetaka Uramoto collaborates with scholars based in Japan, China and Sweden. Hidetaka Uramoto's co-authors include Fumihiro Tanaka, Takeshi Hanagiri, Kosei Yasumoto, Tsunehiro Oyama, Kimitoshi Kohno, Hiroto Izumi, Kenji Sugio, Hidehiko Shimokawa, Takamitsu Onitsuka and Kenji Ono and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hidetaka Uramoto

304 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy

2003 543 citations Hiroto Izumi, Hidetaka Uramoto et al. profile →
Recurrence after surgery in patients with NSCLC.

2014 423 citations Hidetaka Uramoto, Fumihiro Tanaka PubMed profile →

Peers

Countries citing papers authored by Hidetaka Uramoto

Since Specialization

Citations

This map shows the geographic impact of Hidetaka Uramoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetaka Uramoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetaka Uramoto more than expected).

Fields of papers citing papers by Hidetaka Uramoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetaka Uramoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetaka Uramoto. The network helps show where Hidetaka Uramoto may publish in the future.

Co-authorship network of co-authors of Hidetaka Uramoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetaka Uramoto. A scholar is included among the top collaborators of Hidetaka Uramoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetaka Uramoto. Hidetaka Uramoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic Impact of Recurrence Pattern for Surgically Resected Non-Small Cell Lung Cancer 2025 ·Oncology ·Nozomu Motono, (unknown), (unknown), Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto	0
2	Successful surgical treatment of an intraoperatively ruptured lung abscess rupture using free pericardial fat implantation: a case report 2024 ·SHILAP Revista de lepidopterología ·Yoshihito Iijima, (unknown), (unknown), Shun Iwai, Nozomu Motono, Hidetaka Uramoto	0
3	A prospective 10-year follow-up study after sublobar resection for ground-glass opacity-dominant lung cancer 2024 ·Scientific Reports ·Hirohisa Kato, Satoshi Shiono, Hiroyuki Suzuki, Hidetaka Uramoto, Jiro Abe, Sumiko Maeda, (unknown), Hiroyuki Deguchi, Makoto Endo, Nobuyuki Sato, (unknown), (unknown), Motoyasu Sagawa, Hirotsugu Notsuda, Yoshinori Okada	0
4	Initial response to the 2024 Noto earthquake by the university hospital closest to the disaster area 2024 ·Scientific Reports ·Hidetaka Uramoto, Takeo Shimasaki, Hiroshi Sasaki, Yoshitsugu Iinuma, Yasuhiro Kawasaki, Norio Kawahara	1
5	Predictive Value of Recurrence of Solid and Micropapillary Subtypes in Lung Adenocarcinoma 2023 ·Oncology ·Nozomu Motono, (unknown), (unknown), Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto	2
6	PRDX4 Improved Aging-Related Delayed Wound Healing in Mice 2021 ·Journal of Investigative Dermatology ·(unknown), Xin Guo, (unknown), (unknown), (unknown), (unknown), Hidetaka Uramoto, Takashi Mochizuki, Sohsuke Yamada	19
7	Clinical significance of bifocal treatment for synchronous brain metastasis in T1-2 non-small-cell lung cancers: JNETS0301 2021 ·General Thoracic and Cardiovascular Surgery ·Katsuyuki Suzuki, Satoshi Shiono, (unknown), Akira Sakurada, (unknown), Nobuyuki Sato, Hidetaka Uramoto, Hiroyuki Deguchi, Jun Suzuki, Yoshinori Okada	3
8	The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma 2018 ·Antioxidants and Redox Signaling ·Xin Guo, Hirotsugu Noguchi, Naoki Ishii, Takujiro Homma, Taiji Hamada, Tsubasa Hiraki, Jing Zhang, (unknown), Seiya Yokoyama, Hiroaki Ishibashi, Tomoko Fukushige, Takuro Kanekura, Junichi Fujii, Hidetaka Uramoto, Akihide Tanimoto, Sohsuke Yamada	26
9	Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling 2013 ·Cancer Research ·(unknown), Akihiko Kawahara, Kosuke Watari, Yûichi Murakami, Kahori Sonoda, (unknown), Hideaki Fujita, Masayoshi Kage, Hidetaka Uramoto, Carlota Costa, Michihiko Kuwano, Mayumi Ono	129
10	Six Cases of Lung Adenocarcinoma Successfully Treated Using Alternate Day Administration of Gefitinib 2013 ·Haigan ·Teruo Iwata, Taiji Kuwata, (unknown), Hidetaka Uramoto, Fumihiro Tanaka	1
11	A case of chondrosarcoma originating in the rib 2013 ·The Journal of the Japanese Association for Chest Surgery ·(unknown), Teruo Iwata, (unknown), Hidetaka Uramoto, Takeshi Hanagiri, Fumihiro Tanaka	0
12	Prognostic value of acquired resistance-related molecules in Japanese patients with NSCLC treated with an EGFR-TKI. 2012 ·PubMed ·Hidetaka Uramoto, Tadaaki Yamada, Seiji Yano, (unknown), Seiki Hasegawa, Fumihiro Tanaka	23
13	Clinical significance of human leukocyte antigen loss and melanoma-associated antigen 4 expression in smokers of non-small cell lung cancer patients 2012 ·International Journal of Clinical Oncology ·Tetsuro Baba, (unknown), Koji Kuroda, Yoshiki Shigematsu, Yoshinobu Ichiki, Hidetaka Uramoto, Takeshi Hanagiri, Fumihiro Tanaka	11
14	The prognostic significance of HER2 overexpression in non-small cell lung cancer. 2011 ·PubMed ·Masaru Takenaka, Takeshi Hanagiri, Shinji Shinohara, Taiji Kuwata, Yasuhiro Chikaishi, (unknown), Yoshiki Shigematsu, Yoshika Nagata, Hidehiko Shimokawa, Makoto Nakagawa, Hidetaka Uramoto, Tomoko So, Fumihiro Tanaka	32
15	Clinical Relevance of TAp73 and ΔNp73 Protein Expression in Ovarian Cancer 2011 ·International Journal of Gynecological Pathology ·Gerda Hofstetter, Astrid Berger, (unknown), Elisabeth Müller‐Holzner, Daniel Reimer, Hanno Ulmer, Hidetaka Uramoto, Christian Marth, Alain G. Zeimet, Robert Zeillinger, Nicole Concin	9
16	Loss of PTEN Expression by Blocking Nuclear Translocation of EGR1 in Gefitinib-Resistant Lung Cancer Cells Harboring Epidermal Growth Factor Receptor–Activating Mutations 2010 ·Cancer Research ·Chizuko Yamamoto, Yuji Basaki, Akihiko Kawahara, Kazutaka Nakashima, Masayoshi Kage, Hiroto Izumi, Kimitoshi Kohno, Hidetaka Uramoto, Kosei Yasumoto, Michihiko Kuwano, Mayumi Ono	141
17	EGFR-activating mutations are not present in breast tumors of Japanese patients. 2010 ·PubMed ·Hidetaka Uramoto, Hidehiko Shimokawa, Yoshika Nagata, Kenji Ono, Takeshi Hanagiri	7
18	Dysregulation of Platelet-Derived Growth Factor β-Receptor Expression by ΔNp73 in Neuroblastoma 2009 ·Molecular Cancer Research ·Daniel Wetterskog, (unknown), Toshinori Ozaki, Hidetaka Uramoto, Akira Nakagawara, Keiko Funa	8
19	Expression of FHIT in esophageal epithelium and carcinoma: reference to drinking, smoking and multicentric carcinogenesis. 2006 ·PubMed ·Masaru Morita, Tsunehiro Oyama, Shoji Nakata, Kenji Ono, Masakazu Sugaya, Hidetaka Uramoto, Takashi Yoshimatsu, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto	11
20	Treatment Results of Bilobectomy in Lung Cancer. 2000 ·Haigan ·Hidetaka Uramoto, Toshihiro Osaki, Yoshinobu Ichiki, Naohiro Nose, Hideyuki Imoto, (unknown), Tsunehiro Oyama, Mantaro Kodate, Kosei Yasumoto	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact